Naaz R, Chand S, Nandakumar U. P, Vinay B. C, Raj K. C. B, Shetty S. Prospective Observational Study on Prescribing Pattern of Antifungal Drugs in the 400 Out-Patient Department of Dermatology in a Tertiary Care Hospital. Biomed Pharmacol J 2021;14(1).

---

Manuscript received on :01-04-2020
Manuscript accepted on :16-01-2021
Published online on: 27-01-2021

---

Plagiarism Check: Yes
Reviewed by: Dr. Nicolas Padilla  
Second Review by: Dr. Ankur Singh Bist  
Final Approval by: Dr. Ayush Dogra  

---

How to Citeclose    |   Publication History close

 Views: (Visited 1,421 times, 1 visits today)    PDF Downloads: 559

Rashmeen Naaz¹, Sharad Chand¹, Nandakumar UP¹, Vinay BC¹ , Bharath Raj KC ¹*and Shricharith Shetty²

¹Department of pharmacy practice, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangaluru, Karnataka, India-575018

²Department of Dermatology and Venerology, Justice K.S. Hegde Medical Acadamy and Hospital, Nitte (Deemed to be University), Mangaluru, Karnataka, India-575018

Corresponding Author E-mail: bharathraj@nitte.edu.in

DOI : https://dx.doi.org/10.13005/bpj/2127

Abstract

Introduction: Fungal infections have been a serious disease over a few decades. Superficial fungal infections not only cause life-threatening illnesses but slowly reduce the Quality of life of patients. Objective: To study the prescribing pattern of antifungal drugs, distribution of fungal disease, and cost variability between different antifungal drugs prescribed. Materials and methods: Prospective observational study was carried out at Justice K.S. Hegde Charitable Hospital from August 2018 to April 2019. Outpatient departments patient satisfying the inclusion criteria were included in the study. Factors like age, gender, diagnosis, and type of prescribed antifungal drugs along with Price variability among different brands of the drug were considered. Antifungal drug prescriptions of patients were analyzed. Results: More than 50% of the patients were from age 21-40 yrs. Males (51.8%) were more than females (48%). The majority of the drugs prescribed were topically (64%). Tine a corpor is was the most prevalent fungal disease. The Azoles group of Antifungal was most prescribed. And the percentage variability between different brands was high. Conclusion: The study concluded the extensive use of antifungal agents. The highly prescribed drug was found to be luliconazole. The study also concluded that the use of generic prescriptions might reduce the cost of illness and enhance the rational use of the drug.

Keywords

Antifungal; Prescribing Pattern; Price Variability; Superficial Infection

Introduction

Skin is the most sensitive as well as the outer most layer of the human body; hence it is having direct contact with all the trigger factors that cause a variety of infections and diseases. Some of the factors that lead to skin diseases mainly in developing countries like India include Ignorance, Low hygiene, Improper sanitization, Drastic climatic change, Overcrowding[1]. Forseveraldecadessuperficialfungalinfectionshavebeenaseriousdiseasetothepatients. Appropriate use of antifungal drugs is very important to treat the patient as well as their complications. Irrational prescribing and also inappropriate use of these drugs may lead to some adverse effects, some persistent infections, unwanted medicinal exposure and also may lead to an increase in the treatment cost. That is why it is very much important to analyze the rationality of the prescription pattern of the drugs[2]. The earliest known fungal infections which are most common throughout the world are Tine a corporisal so known as ring worm and Tine a crurisal so known as jockitch. However, these Tine a corporis and Tine a cruris may not cause mortality but, it is a very big cause for morbidity and also possesses a major health problem or condition[3]. Mostly all the tine a infection is treated with antifungal agents. Large varieties of systemic as well as topical antifungal agents are available in the market.Some newer antifungal agents are flooding into the market in current days e.g., eberconazole and posacon azole[4]. Prescribing of the brand drug is very common amongst most of the dermatology department outside clinics as well as in hospital settings [5-8]. Expensive brand drugs increase the financial burden for the patients because the majority of the fungal infections are chronic and they require long term treatment regimens[9]. Hence this study aims to evaluate the prescription pattern, distribution of fungal disease & its comorbidities and price variability of antifungal drugs.

Materials and Methods

A prospective observational study was carried out in an outpatient of the dermatology department of Justice K.S. Hegde Charitable Hospital. And the calculated sample size was approximately 400 samples by using formula at a 95% confidence interval with 5% of precision and 12% of anticipated precision. The duration of the study was eight months. Patients of either gender above eighteen years of age visiting the dermatology department knowing at least English or Kannada or Malayalam were included in the study. Before starting the study ethical approval was obtained from the institutional ethics committee (REF: NGSMIPS/IEC/17/2018-19). And patient informed consent was obtained voluntarily. Data collection was done only after getting permission from the respected hospital authorities.

The prescription was reviewed, and necessary data were collected including the age, gender, diagnosis, dosage, frequency, route of administration, name of the drug, dosage form, and duration of treatment along with the cost of the drug. Drugs with only one brand available were excluded, where as the cost per tablet of a particular drug of various dosage forms and strengths, manufactured by different companies were compared. Cost differences between the minimum and maximum costs of similar drugs were calculated. Percentage price variation for all brands of Antifungal drugs was calculated by using the formula:

Percentage variation =

Data were analyzed using descriptive statistics. The frequency with percentage was used to summarize the demographics of the patient, indications, prescribing pattern of Antifungal drugs, and route of administration. alysis of the data was carried out by using Statistical Package for Social Science (SPSS) 20.0 for windows.

Results

Gender And Age-Wise Distribution

Four hundred patients were enrolled in the study, out of which 207(51.8%) were males and 193 were females (48.3%). The majority of the patients belong to the age group were 21 to 40 years (55%). Age-wise distribution of the patients is given in table 1.

Table 1: Age wise distribution

Distribution of Prescribed Antifungal Drugs

Out of 400 prescriptions taken in the study, it was found that total of about eight antifungal drugs wasprescribed: Ketoconazole (30%), Miconazole (13.5%), Luliconazole (33.8%), Fluconazole (12%) Itraconazole(24.8%), Eberconazole (0.8%), Terbinafine(28.1%), and Clotrimazole (15%).

Route of Administration

In this study of 400 prescriptions of antifungal drugs, it has been noticed that (36%) drugs were prescribed orally, and 64% were prescribed topically

Analysis of Topical Antifungal Drugs

Here in this study, it was found that Ketoconazole (30%), luliconazole (33.8%), Miconazole (13.5%), Eberconazole (0.8%), Clotrimazole (15%) were topically prescribed antifungal drugs.

Analysis of Oral and Topical Antifungal Agents

In the study here, Fluconazole (12%), Itraconazole (24.8%), Terbinafine (28%) were the three different drugs given orally as well as topically.

Distribution of the Total Number of Prescribed Antifungal Drugs Per Patients

In this study of 400 prescriptions, 200 patients that is 101 males and 99 females, received a prescription was only one antifungal drug was prescribed. And 172 patients were 90 males and 82 females received prescription were two antifungal drugs were prescribed. Then 26 patients received prescription was three antifungal drugs was prescribed out of which 15 were male and 11 were females. Two patients received a prescription were four antifungal were prescribed that is one male and one female.

Distribution of Antifungal Drug Groups

From the study, we have found that prescribed antifungal drugs belonging to three different groups and shown in figure 1.

Figure 1: Different groups of antifungal drugs Click here to view figure

Distribution Of Fungal Infections – Single lesions

Different types of Single lesion fungal infection found in this study where tinea corporis and tinea cruris are in the highest frequency and are as shown in table 2.

Table 2: Fungal infections – single lesions

Distribution of Different Types of Tinea Observed in Prescription

In this study of out 400 prescriptions, it has been found that there are different types of tinea: namely Tinea incognito (0.3%), Tineapedis(3%), Tineafacei(2%), Tineacorporis(33%), and Tineacruris(25.8%). Out of all these tinea corporis followed by tinea cruris was the most found fungal infections.

Distribution of co-prescribed antihistamines with antifungals

It was found that levocetirizine, followed by hydroxyzine, was the most commonly prescribed antihistaminics. Details are shown in table no 3.

Table 3: Distribution of co prescribed antihistaminics

Types of Topical Formulation

There are different types of topical formulation found in this prescription study. For example, creams/ ointments, shampoos, lotions,sunscreen, moisturizer/ emollient, face wash, powders, soap, mouth paint etc. It has been found that creams and ointments are prescribed in maximum (69.8%), followed by lotions (19.3%) the details are referenced in table no 4.

Table 4: Types of Topical Formulations

Price Variability Study

In this study, ketoconazole shows maximum price variation (264.70%) followed by itraconazole (231.63%), and the least price variation is seen in terbinafine. The complete detail is explained in table 5.

Table 5: price variability study

Discussion

Medicine prescribing has a pivotal role in the health care system. Time to time evaluation of prescription is also very much important for proper drug utilization and proper patient compliance. In this study, the usage pattern of antifungals was observed, and the results found that the majority of the antifungal drugs were prescribed topically (64%) than orally (36%). The reason behind this is topical drugs have the least side effects and also easy application. Generic prescription is considered as the most rational and economical method of prescribing [7]. But here, the branded drug dominated the prescription.It has been found that 55% of the patient’s age group falls in 21-40 years, and the males were more compared to females, which is similar to results of Rohini et al. where they had more than 50% of patients in the age group 21-40 yrs [10, 11].After topical luliconazole, ketoconazole was the second most prescribed antifungal drug (30%). This was contradictory to a study conducted by Minocha et al., Sultana et al., and Khalid et al. where they reported the terbinafine and clotrimazole, fluconazole and terbinafine and fluconazole and nystatin as most commonly used antifungal drugs respectively [12-14].

Here in this study, tine a corporis (33%) followed by tine a cruris was the most commonly diagnosed fungal function. The other diagnosis such as intertrigo, pityrias is Versicolor, candidiasis, tine a pedis, tine a facei and many more diagnosis were comparatively less observed in the study .its results are in accordance with another study which was conducted by Yogesh et al. in Nepal [15]. Azoles group of antifungal drugs (imidazole 78.1% and triazole36.8%respectively) dominated the prescription and there was also the prescription of all ylamines in the study (28.1%). The study showed that the cost of the prescription was found to be high because of the prescription of branded drugs and percentage variability of the cost of the drug was also high. Percentage variability seen in ketoconazole is 264.70 %, followed byItraconazole 231.63% which is in accordance with other studies conducted by Sumana et al., Saleem et al., Anuj et al., and Suhaina et al. [1, 3, 16, 17].

Conclusion

The study focused mainly on antifungal drug prescribing patterns in the outpatient department of dermatology. The study also showed that the use of newer antifungal drug prescription is highly increasing. The most commonly prescribed antifungal drug here was found to be Luliconazole which is a newer Azole antifungal agent used topically. The use of generic prescriptions must be initiated using some medical education programs so that there will be some reduction in the cost of prescription and also makes the prescription pattern more rational and economical.

Acknowledgment

We Authors are extremely thankful to Nitte (Deemed to be University), KSHEMA, NGSMIPS. Mangaluru, Karnataka for providing us all the necessary facilities for carrying out this work.

Conflict of Interest

Authors declare no conflict of interest

References

1. Sumana MH, Santhosh Kumar. Prescription analysis of drugs used in outpatient department of dermatology at tertiary care hospital.Asian J of Biomedical and Pharm sciences.2015; 5(46):13-15.
   CrossRef
2. Vishal P, Om P. Drug prescribing pattern in dermatophytosis at medicaloutpatient clinic at tertiary healthcare in Karnataka. Med science.2015;4(3):2465-72.
   CrossRef
3. Saleem TK, Dilip C, Nishad VK, Assessment of drug prescribing pattern indermatology outpatient department in a tertiary care hospital MalabarKerala. Ind J Pharm Pract.2012;5(3):62-8.
4. Vegada BN, Karelia BN, Singh AP. Drug utilization study of Antifungal usedin the Department of Skin and VD of a tertiary care hospital. Int J Pharm Sci RevRes.2015;34(1): 118-21.
5. Rajathilagam, Tasneem S, Rajagopalan V, Jamuna R. A study of prescribing pattern of antifungal drug in dermatology outpatient department.Int J Bio and Pharm research.2012; 3(8):968-73.
6. Gouda V, Shastry C.S., Mateti UV, et al. Study on steroid utilization patterns in general medicine department. Research J. Pharm. And Tech. 2019; 12(10): 4777-4781.
   CrossRef
7. Al-jabri MM, Shastry CS, Chand S. Assessment of Drug Utilization pattern in Chronic Kidney Disease Patients in a Tertiary Care Hospital Based on WHO Core Drug Use Journal of Global Pharma Technology, 2019; 11(09): 1-9.
8. D’souza AM, Shastry C.S., Mateti UV, et al. Drug Utilization and Evaluation of Proton Pump Inhibitors in General Medicine Ward of a Tertiary Care Hospital. J. Pharm. Sci. & Res. 2019; 11(6): 2174-2179.
9. Chandran BK, Vaddakkan K, Altaf M, et al. A retrospective study on postoperative usage pattern of analgesics in orthopedics department of a tertiary care teaching hospital. International Journal of Scientific and technology research. 2020; 9(03): 1207-1211.
10. Farida I, Siti F. Evaluation of appropriate use of antifungal therapy in atertiary care hospital. Asian J Pharm and clin research. 2015;8(4):195-99.
11. Rohini G, Akash K, Kamagonda J, Sadiq P, Sanket G. Analysis ofprescribing pattern of drugs among patients attending dermatology outpatient department of a tertiary care hospital. Euro J Pharm And MedResearch. 2018;5(3):259-73.
12. Minocha KB, Sanjay B, Kanchan G, Monisha G. A clinic pharmacologicalstudy of outpatient prescribing pattern of dermatological drugs in Indiantertiary hospital. Ind J Pharmco. 2000;32:384-85.
13. Sultana T, Saha SK, Hossain M, Sarker M, Das PK. Current trends of usingsystemic antifungals and their comparative efficacy in tineacorporis and tineacruris in outpatientdepartment of dermatology in a tertiary levelhospital. Mymensingh Med J. 2018;27(1):52-6.
14. Khalid B, Mohammed A, Fathma A. Prescribing pattern of antifungalmedication at a tertiary care hospital in Oman. J clindiagno research.2016;10(12):FC27-30.
15. Yogesh P, Shambhu D. Medication practice of patients with dermatophytosis. J Nepal Med Assoc. 2016;55(203):7-10.
    CrossRef
16. Anuj K, Subodh K, Lalith M, Harihar D. study of drug utilization pattern forskin diseases in dermatology OPD of a Indian Tertiary care hospital. Jclindiagno research. 2016;10(2):FC01-05.
17. Suhaina AS, Reneega G. Drug prescribing pattern with cost analysis andmonitoring of adverse drug reactions in dermatology.Int J SciStud.2018;6(8):146